BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modlin IM, Shapiro MD, Kidd M. Carcinoid tumors and fibrosis: an association with no explanation. Am J Gastroenterol. 2004;99:2466-2478. [PMID: 15571597 DOI: 10.1111/j.1572-0241.2004.40507.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
2 Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med. 2006;4:23. [PMID: 17026742 DOI: 10.1186/1741-7015-4-23] [Cited by in Crossref: 166] [Cited by in F6Publishing: 140] [Article Influence: 10.4] [Reference Citation Analysis]
3 Herring B, Jang S, Whitt J, Goliwas K, Aburjania Z, Dudeja V, Ren B, Berry J, Bibb J, Frost A, Chen H, Rose JB, Jaskula-Sztul R. Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates. Front Endocrinol (Lausanne) 2021;12:710009. [PMID: 35002949 DOI: 10.3389/fendo.2021.710009] [Reference Citation Analysis]
4 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
5 Bendelow J, Apps E, Jones L, Poston G. Carcinoid syndrome. European Journal of Surgical Oncology (EJSO) 2008;34:289-96. [DOI: 10.1016/j.ejso.2007.07.202] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
6 Laskaratos FM, Levi A, Schwach G, Pfragner R, Hall A, Xia D, von Stempel C, Bretherton J, Thanapirom K, Alexander S, Ogunbiyi O, Watkins J, Luong TV, Toumpanakis C, Mandair D, Caplin M, Rombouts K. Transcriptomic Profiling of In Vitro Tumor-Stromal Cell Paracrine Crosstalk Identifies Involvement of the Integrin Signaling Pathway in the Pathogenesis of Mesenteric Fibrosis in Human Small Intestinal Neuroendocrine Neoplasms. Front Oncol 2021;11:629665. [PMID: 33718208 DOI: 10.3389/fonc.2021.629665] [Reference Citation Analysis]
7 Scott AT, Howe JR. Management of Small Bowel Neuroendocrine Tumors. J Oncol Pract. 2018;14: 471-482. [PMID: 30096273 DOI: 10.1200/jop.18.00135] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
8 Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367:241-251. [PMID: 16427494 DOI: 10.1016/s0140-6736(06)68035-5] [Cited by in Crossref: 448] [Cited by in F6Publishing: 99] [Article Influence: 28.0] [Reference Citation Analysis]
9 Rubin de Celis Ferrari AC, Glasberg J, Riechelmann RP. Carcinoid syndrome: update on the pathophysiology and treatment. Clinics (Sao Paulo). 2018;73:e490s. [PMID: 30133565 DOI: 10.6061/clinics/2018/e490s] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
10 McCall CM, Shi C, Klein AP, Konukiewitz B, Edil BH, Ellison TA, Wolfgang CL, Schulick RD, Klöppel G, Hruban RH. Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. Hum Pathol. 2012;43:1169-1176. [PMID: 22221702 DOI: 10.1016/j.humpath.2011.09.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
11 Mota JM, Sousa LG, Riechelmann RP. Complications from carcinoid syndrome: review of the current evidence. Ecancermedicalscience. 2016;10:662. [PMID: 27594907 DOI: 10.3332/ecancer.2016.662] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
12 Haugaa KH, Bergestuen DS, Sahakyan LG, Skulstad H, Aakhus S, Thiis-Evensen E, Edvardsen T. Evaluation of right ventricular dysfunction by myocardial strain echocardiography in patients with intestinal carcinoid disease. J Am Soc Echocardiogr 2011;24:644-50. [PMID: 21440415 DOI: 10.1016/j.echo.2011.02.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
13 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
14 Ratnayake GM, Laskaratos FM, Mandair D, Caplin ME, Rombouts K, Toumpanakis C. What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms? Curr Oncol Rep 2022. [PMID: 35554845 DOI: 10.1007/s11912-022-01211-5] [Reference Citation Analysis]
15 Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the diffuse neuroendocrine system. Curr Opin Oncol. 2008;20:1-12. [PMID: 18043250 DOI: 10.1097/cco.0b013e3282f1c595] [Cited by in Crossref: 90] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
16 Cunningham JL, Tsolakis AV, Jacobson A, Janson ET. Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of alpha-smooth muscle actin. Eur J Endocrinol. 2010;163:691-697. [PMID: 20660557 DOI: 10.1530/eje-10-0420] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Jacobson A, Cunningham JL. Connective tissue growth factor in tumor pathogenesis. Fibrogenesis Tissue Repair. 2012;5:S8. [PMID: 23259759 DOI: 10.1186/1755-1536-5-s1-s8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
18 Tamagno G, Sheahan K, Skehan SJ, Geoghegan JG, Fennelly D, Collins CD, Maguire D, Traynor O, Brophy DP, Cantwell C, Swan N, McGowan L, O'Toole D, O'Shea D. Initial impact of a systematic multidisciplinary approach on the management of patients with gastroenteropancreatic neuroendocrine tumor. Endocrine. 2013;44:504-509. [PMID: 23471696 DOI: 10.1007/s12020-013-9910-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
19 Kidd M, Modlin I, Shapiro M, Camp R, Mane S, Usinger W, Murren J. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol 2007; 13(39): 5208-5216 [PMID: 17876891 DOI: 10.3748/wjg.v13.i39.5208] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
20 Blažević A, Zandee WT, Franssen GJH, Hofland J, van Velthuysen MF, Hofland LJ, Feelders RA, de Herder WW. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours. Endocr Relat Cancer 2018;25:245-54. [PMID: 29255095 DOI: 10.1530/ERC-17-0282] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
21 Anderson WF, Rabkin CS, Turner N, Fraumeni JF Jr, Rosenberg PS, Camargo MC. The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites. J Natl Cancer Inst. 2018;110:608-615. [PMID: 29361173 DOI: 10.1093/jnci/djx262] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 24.3] [Reference Citation Analysis]
22 Peixoto RD, Al-Barrak J, Lim H, Renouf D. Gastroesophageal cancer and retroperitoneal fibrosis: Two case reports and review of the literature. World J Gastrointest Oncol 2013; 5(3): 68-70 [PMID: 23671733 DOI: 10.4251/wjgo.v5.i3.68] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
23 Hauso O, Gustafsson BI, Nordrum IS, Waldum HL. The effect of terguride in carbon tetrachloride-induced liver fibrosis in rat. Exp Biol Med (Maywood) 2008;233:1385-8. [PMID: 18703754 DOI: 10.3181/0804-RM-137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
24 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
25 Kitchens WH, Elias N, Blaszkowsky LS, Cosimi AB, Hertl M. Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor. World J Surg Oncol 2011;9:11. [PMID: 21281518 DOI: 10.1186/1477-7819-9-11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
26 Raut CP, Kulke MH, Glickman JN, Swanson RS, Ashley SW. Carcinoid Tumors. Current Problems in Surgery 2006;43:391-450. [DOI: 10.1067/j.cpsurg.2006.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson's disease. The Lancet Neurology 2005;4:423-31. [DOI: 10.1016/s1474-4422(05)70119-8] [Cited by in Crossref: 78] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
28 Modlin IM, Latich I, Zikusoka M, Kidd M, Eick G, Chan AKC. Gastrointestinal Carcinoids: The Evolution of Diagnostic Strategies: . Journal of Clinical Gastroenterology 2006;40:572-82. [DOI: 10.1097/00004836-200608000-00003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
29 Mokhles P, van Herwerden LA, de Jong PL, de Herder WW, Siregar S, Constantinescu AA, van Domburg RT, Roos-hesselink JW. Carcinoid heart disease: outcomes after surgical valve replacement. European Journal of Cardio-Thoracic Surgery 2012;41:1278-83. [DOI: 10.1093/ejcts/ezr227] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
30 Moreira RK, Washington K. Pathology of Gastrointestinal Neuroendocrine Tumors: An Update. Surg Pathol Clin 2010;3:327-47. [PMID: 26839134 DOI: 10.1016/j.path.2010.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Svejda B, Kidd M, Giovinazzo F, Eltawil K, Gustafsson BI, Pfragner R, Modlin IM. The 5-HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment. Cancer 2010;116:2902-12. [DOI: 10.1002/cncr.25049] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
32 Valentino JD, Li J, Zaytseva YY, Mustain WC, Elliott VA, Kim JT, Harris JW, Campbell K, Weiss H, Wang C, Song J, Anthony L, Townsend CM Jr, Evers BM. Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors. Clin Cancer Res 2014;20:1212-22. [PMID: 24443523 DOI: 10.1158/1078-0432.CCR-13-1897] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
33 Kabir T, Issa M, Starkey G. Rare presentation of a symptomatic primary neuroendocrine tumour of small bowel mesentery. ANZ J Surg 2021;91:E403-4. [PMID: 33159428 DOI: 10.1111/ans.16431] [Reference Citation Analysis]
34 Lipton S, Schwab P. Neoplasm Mimics of Rheumatologic Presentations: Sialadenitis, Ocular Masquerade Syndromes, Retroperitoneal Fibrosis, and Regional Pain Syndromes. Rheumatic Disease Clinics of North America 2011;37:623-37. [DOI: 10.1016/j.rdc.2011.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
35 Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, Horn A, Jüngel A, Beyer C, Krönke G, Zwerina J, Reiter R, Alenina N, Maroteaux L, Gay S, Schett G, Distler O, Distler JH. Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med 2011;208:961-72. [PMID: 21518801 DOI: 10.1084/jem.20101629] [Cited by in Crossref: 173] [Cited by in F6Publishing: 161] [Article Influence: 15.7] [Reference Citation Analysis]
36 Rastogi V, Singh D, Mazza JJ, Parajuli D, Yale SH. Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila. Clin Med Res 2018;16:16-28. [PMID: 29650525 DOI: 10.3121/cmr.2017.1379a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
37 Subash N, Papali MM, Bahadur KP, Avanthika C, Jhaveri S, Thannir S, Joshi M, Valisekka SS. Recent Advances in the Diagnosis and Management of Carcinoid Syndrome. Dis Mon 2021;:101304. [PMID: 34972546 DOI: 10.1016/j.disamonth.2021.101304] [Reference Citation Analysis]
38 Sugahara KN, Scodeller P, Braun GB, de Mendoza TH, Yamazaki CM, Kluger MD, Kitayama J, Alvarez E, Howell SB, Teesalu T, Ruoslahti E, Lowy AM. A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis. J Control Release 2015;212:59-69. [PMID: 26071630 DOI: 10.1016/j.jconrel.2015.06.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
39 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
40 Guilmette J, Nosé V. Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms. Semin Diagn Pathol 2019;36:229-39. [PMID: 30910348 DOI: 10.1053/j.semdp.2019.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 La Rosa S, Franzi F, Albarello L, Schmitt A, Bernasconi B, Tibiletti MG, Finzi G, Placidi C, Perren A, Capella C. Serotonin-Producing Enterochromaffin Cell Tumors of the Pancreas: Clinicopathologic Study of 15 Cases and Comparison With Intestinal Enterochromaffin Cell Tumors. Pancreas 2011;40:883-95. [DOI: 10.1097/mpa.0b013e31822041a9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
42 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
43 Clement D, Ramage J, Srirajaskanthan R. Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome. J Oncol 2020;2020:8341426. [PMID: 32322270 DOI: 10.1155/2020/8341426] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
44 Habib G, Bucciarelli-Ducci C, Caforio ALP, Cardim N, Charron P, Cosyns B, Dehaene A, Derumeaux G, Donal E, Dweck MR, Edvardsen T, Erba PA, Ernande L, Gaemperli O, Galderisi M, Grapsa J, Jacquier A, Klingel K, Lancellotti P, Neglia D, Pepe A, Perrone-Filardi P, Petersen SE, Plein S, Popescu BA, Reant P, Sade LE, Salaun E, Slart RHJA, Tribouilloy C, Zamorano J; EACVI Scientific Documents Committee., Indian Academy of Echocardiography. Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the "Working Group on myocardial and pericardial diseases" of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography. Eur Heart J Cardiovasc Imaging 2017;18:1090-121. [PMID: 28510718 DOI: 10.1093/ehjci/jex034] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 10.8] [Reference Citation Analysis]
45 van Gerven MA, Jurgelenaite R, Taal BG, Heskes T, Lucas PJ. Predicting carcinoid heart disease with the noisy-threshold classifier. Artificial Intelligence in Medicine 2007;40:45-55. [DOI: 10.1016/j.artmed.2006.09.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
46 Blažević A, Hofland J, Hofland LJ, Feelders RA, de Herder WW. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum. Endocr Relat Cancer 2018;25:R115-30. [PMID: 29233841 DOI: 10.1530/ERC-17-0380] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
47 La Salvia A, Portigliatti Pomeri A, Persano I, Trevisi E, Parlagreco E, Colombi N, Brizzi MP, Picci RL, Oliva F. Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review. Compr Psychiatry 2021;109:152244. [PMID: 34120056 DOI: 10.1016/j.comppsych.2021.152244] [Reference Citation Analysis]
48 Moncayo R. Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis. EJNMMI Res 2011;1:9. [PMID: 22214590 DOI: 10.1186/2191-219X-1-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
49 Derakhshandeh R, Sanadhya S, Lee Han K, Chen H, Goloubeva O, Webb TJ, Younis RH. Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype. Oncotarget 2018;9:11126-44. [PMID: 29541402 DOI: 10.18632/oncotarget.24277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
50 Modlin IM, Latich I, Kidd M, Zikusoka M, Eick G. Therapeutic options for gastrointestinal carcinoids. Clin Gastroenterol Hepatol. 2006;4:526-547. [PMID: 16630755 DOI: 10.1016/j.cgh.2005.12.008] [Cited by in Crossref: 105] [Cited by in F6Publishing: 91] [Article Influence: 6.6] [Reference Citation Analysis]
51 Scott AT, Howe JR. Management of Small Bowel Neuroendocrine Tumors. Surg Oncol Clin N Am 2020;29:223-41. [PMID: 32151357 DOI: 10.1016/j.soc.2019.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
53 Gustafsson BI, Hauso O, Drozdov I, Kidd M, Modlin IM. Carcinoid heart disease. Int J Cardiol 2008;129:318-24. [PMID: 18571250 DOI: 10.1016/j.ijcard.2008.02.019] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
54 Druce MR, Bharwani N, Akker SA, Drake WM, Rockall A, Grossman AB. Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel. QJM. 2010;103:177-185. [PMID: 20123681 DOI: 10.1093/qjmed/hcp191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
55 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
56 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
57 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
58 Wong M, Kong A, Constantine S, Pathi R, Parrish F, Verma R, Lim C, Steer C. Radiopathological review of small bowel carcinoid tumours. Journal of Medical Imaging and Radiation Oncology 2009;53:1-12. [DOI: 10.1111/j.1754-9485.2009.02031.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
59 Chaturvedi S, Misra DP, Prasad N, Rastogi K, Singh H, Rai MK, Agarwal V. 5-HT2 and 5-HT2B antagonists attenuate pro-fibrotic phenotype in human adult dermal fibroblasts by blocking TGF-β1 induced non-canonical signaling pathways including STAT3 : implications for fibrotic diseases like scleroderma. Int J Rheum Dis 2018;21:2128-38. [PMID: 30207074 DOI: 10.1111/1756-185X.13386] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
60 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
61 Landerholm K, Falkmer S, Järhult J. Epidemiology of Small Bowel Carcinoids in a Defined Population. World J Surg 2010;34:1500-5. [DOI: 10.1007/s00268-010-0519-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
62 Khan MS, Caplin ME. Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2011;18 Suppl 1:S53-74. [PMID: 22005115 DOI: 10.1530/ERC-10-0271] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
63 Milcent K, Franchi-Abella S, Larrar S, Guitton C, Valteau-Couanet D, Koné-Paut I, Bader-Meunier B. [Retroperitonal fibrosis and lymphoma in a 15-year-old boy]. Arch Pediatr. 2008;15:1756-1759. [PMID: 18976891 DOI: 10.1016/j.arcped.2008.09.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
64 van Dijk SC, de Herder WW, Kwekkeboom DJ, Zillikens MC, Feelders RA, van Schaik RH, van Driel M, van Leeuwen JP. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients. Bone 2012;50:1260-5. [PMID: 22425693 DOI: 10.1016/j.bone.2012.02.637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
65 Modlin IM, Shapiro MD, Kidd M. Siegfried Oberndorfer: origins and perspectives of carcinoid tumors. Hum Pathol 2004;35:1440-51. [PMID: 15619202 DOI: 10.1016/j.humpath.2004.09.018] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.6] [Reference Citation Analysis]
66 Laskaratos FM, Davar J, Toumpanakis C. Carcinoid Heart Disease: a Review. Curr Oncol Rep 2021;23:48. [PMID: 33725214 DOI: 10.1007/s11912-021-01031-z] [Reference Citation Analysis]
67 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128:1717-51. [DOI: 10.1053/j.gastro.2005.03.038] [Reference Citation Analysis]
68 Kawamoto S, Shi C, Hruban RH, Choti MA, Schulick RD, Fishman EK, Siegelman SS. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction. AJR Am J Roentgenol 2011;197:W482-8. [PMID: 21862776 DOI: 10.2214/AJR.10.5428] [Cited by in Crossref: 41] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
69 Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128:1717-1751. [PMID: 15887161 DOI: 10.1053/j.gastro.2005.03.038] [Cited by in Crossref: 519] [Cited by in F6Publishing: 422] [Article Influence: 30.5] [Reference Citation Analysis]
70 Lal A, Chen H. Treatment of advanced carcinoid tumors. Curr Opin Oncol 2006;18:9-15. [PMID: 16357558 DOI: 10.1097/01.cco.0000198018.53606.62] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
71 Laskaratos F, Rombouts K, Caplin M, Toumpanakis C, Thirlwell C, Mandair D. Neuroendocrine tumors and fibrosis: An unsolved mystery? Cancer 2017;123:4770-90. [DOI: 10.1002/cncr.31079] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
72 Ruggeri RM, Altieri B, Grossrubatcher E, Minotta R, Tarsitano MG, Zamponi V, MIsidori A, Faggiano A, Colao AM; NIKE Group. Sex differences in carcinoid syndrome: A gap to be closed. Rev Endocr Metab Disord 2022. [PMID: 35292889 DOI: 10.1007/s11154-022-09719-8] [Reference Citation Analysis]
73 Yu JI, Park W, Lee KK, Park W. Scleredema adultorum of Buschke associated with a carcinoid tumor. International Journal of Dermatology 2009;48:784-6. [DOI: 10.1111/j.1365-4632.2009.04029.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
74 Modlin IM, Kidd M, Drozdov I, Siddique ZL, Gustafsson BI. Pharmacotherapy of neuroendocrine cancers. Expert Opin Pharmacother. 2008;9:2617-2626. [PMID: 18803449 DOI: 10.1517/14656566.9.15.2617] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
75 Koumarianou A, Alexandraki KI, Wallin G, Kaltsas G, Daskalakis K. Pathogenesis and Clinical Management of Mesenteric Fibrosis in Small Intestinal Neuroendocine Neoplasms: A Systematic Review. J Clin Med. 2020;9. [PMID: 32521677 DOI: 10.3390/jcm9061777] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
76 deVries H, Wijffels RT, Willemse PH, Verschueren RC, Kema IP, Karrenbeld A, Prins TR, deVries EG. Abdominal angina in patients with a midgut carcinoid, a sign of severe pathology. World J Surg. 2005;29:1139-1142. [PMID: 16086212 DOI: 10.1007/s00268-005-7825-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
77 Fanciulli G, Ruggeri RM, Grossrubatscher E, Calzo FL, Wood TD, Faggiano A, Isidori A, Colao A; NIKE. Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications. Rev Endocr Metab Disord 2020;21:599-612. [PMID: 32152781 DOI: 10.1007/s11154-020-09547-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
78 Pelle E, Al-Toubah T, Morse B, El-Haddad G, Strosberg J. Desmoplastic mesenteric lesions do not respond radiographically to peptide receptor radionuclide therapy. J Neuroendocrinol. 2021;33:e12936. [PMID: 33474756 DOI: 10.1111/jne.12936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Dillon JS. Workup of Gastroenteropancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am 2020;29:165-83. [PMID: 32151354 DOI: 10.1016/j.soc.2019.10.002] [Reference Citation Analysis]
80 Hayes AR, Davar J, Caplin ME. Carcinoid Heart Disease: A Review. Endocrinol Metab Clin North Am 2018;47:671-82. [PMID: 30098723 DOI: 10.1016/j.ecl.2018.04.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
81 Daskalakis K, Karakatsanis A, Stålberg P, Norlén O, Hellman P. Clinical signs of fibrosis in small intestinal neuroendocrine tumours. Br J Surg 2017;104:69-75. [PMID: 27861745 DOI: 10.1002/bjs.10333] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
82 Pipitone N, Salvarani C, Peter H. Chronische Periaortitis. Internist 2010;51:45-52. [DOI: 10.1007/s00108-009-2407-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
83 Druce M, Rockall A, Grossman AB. Fibrosis and carcinoid syndrome: from causation to future therapy. Nat Rev Endocrinol 2009;5:276-83. [PMID: 19444261 DOI: 10.1038/nrendo.2009.51] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
84 Laskaratos FM, Diamantopoulos L, Walker M, Walton H, Khalifa M, El-Khouly F, Koffas A, Demetriou G, Caplin M, Toumpanakis C, Mandair D. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia. Neuroendocrinology 2018;106:366-80. [PMID: 29320779 DOI: 10.1159/000486097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]